September 2026
The insulin delivery devices market size reached USD 22.50 billion in 2026, with leading insulin delivery devices market companies including Novo Nordisk A/S, Wockhardt Ltd., Medtronic.
September 2026
The global insulin drugs and delivery devices market size is evaluated at USD 27.47 billion in 2026 and is predicted to hit around USD 52.72 billion by 2035, growing at a CAGR of 7.52%.
September 2026
The global vaccine delivery devices market size was evaluated at USD 8.69 billion in 2026 and is predicted to hit around USD 17.10 billion by 2035, growing at a CAGR of 7.81%.
September 2026
The global subcutaneous drug delivery devices market size was valued at USD 38.87 billion in 2026 and is projected to hit around USD 74.66 billion by 2035 with a CAGR of 7.53%.
September 2026
The global drug and gene delivery devices market size is projected to hit around USD 1,875.96 million by 2035 from USD 864.96 million in 2026, with a CAGR of 9.00%.
September 2026
The drug delivery devices market size reached USD 321.05 billion in 2026, with leading drug delivery devices market companies including Pfizer, Inc., F. Hoffmann-La Roche Ltd, Johnson and Johnson Private Ltd.
September 2026
The global intranasal drug delivery devices market size surpassed USD 2,043.63 million in 2026 and is projected to hit around USD 4,949.45 million by 2035, with a noteworthy CAGR of 10.33%.
June 2026
The implantable drug delivery devices market size is valued at USD 13.98 billion in 2026 and is expected to hit around USD 22.01 billion by 2035 with a CAGR of 5.17%.
September 2026
The injectable drug delivery market reached USD 829.98 billion in 2026, with prominent companies such as Sandoz, therumo, schott ag, gerresheimer, ypsormed leading the injectable drug delivery market.
September 2026
The medical aesthetic devices market size reached USD 23.85 billion in 2026, with leading medical aesthetic devices market companies including medical aesthetic devices, Cutera Inc., InMode Ltd., Alma Lasers.
September 2026
The blood clot retrieval devices market size reached USD 2.40 billion in 2026, with leading blood clot retrieval devices market companies including AngioDynamics, Terumo Co., Johnson and Johnson.
September 2026
The global neurostimulation devices market size is valued at USD 15.56 billion in 2026 and is expected to hit around USD 40.80 billion by 2035, growing at a CAGR of 11.35%.
September 2026
The anastomosis devices market size reached USD 5.76 billion in 2026, with leading anastomosis devices market companies including B. Braun Medical, Getinge AB, CONMED Corporation.
September 2026
The advanced drug delivery market size is calculated at USD 103.84 billion in 2026 and is projected to hit around USD 371.83 billion by 2035 with a CAGR of 15.26%.
September 2026
The global smart insulin pens market size was exhibited at USD 212.57 million in 2026 and is projected to hit around USD 676.01 million by 2034 with a CAGR of 15.23%.
September 2026
The anesthesia devices market size reached USD 20.61 billion in 2026, with leading anesthesia devices market companies including Ambu A/S, Becton, Dickinson and Company, Dragerwerk AG & Co. KGaA.
September 2026
The global breast biopsy devices market size was calculated at USD 1.18 billion in 2026 and is expected to surge around USD 1.70 billion by 2035 with a CAGR of 4.17%.
September 2026
The global dermatology diagnostic devices and therapeutics market size is projected to hit around USD 31.33 billion by 2035 from USD 17.03 billion in 2026, with a CAGR of 7.02%.
September 2026
The global thoracic surgery devices market size is calculated at USD 790.92 million in 2024 and is projected to hit around USD 1,466.18 million by 2034 with a CAGR of 6.37%.
September 2026
The global vital signs monitoring devices market size was valued at USD 12.55 billion in 2026 and is expected to reach around USD 25.58 billion by 2035 with a CAGR of 8.27%.
September 2026
The neurovascular thrombectomy devices market size stood at USD 882.16 million in 2026, with major neurovascular thrombectomy devices market companies including Balt Group, Imperative Care.
September 2026
The global gastro-retentive drug delivery systems outsourcing market size is expected to increase from USD 2.17 billion in 2026 to hit around USD 3.86 billion by 2035, growing at a CAGR of 6.58%.
September 2026
The global neurovascular embolization devices market size is estimated to hit around USD 4.58 billion by 2035 increasing from USD 1.68 billion in 2026, with a CAGR of 11.80%.
September 2026
The global life science microscopy devices market size was evaluated at USD 2.33 billion in 2026 and is predicted to hit around USD 3.94 billion by 2035, growing at a CAGR of 6.00%.
September 2026
The global ambulatory cardiac monitoring devices market size is estimated to hit around USD 24.58 billion by 2035 increasing from USD 9.47 billion in 2026, with a CAGR of 11.19%.
September 2026
The global laparoscopy devices market size was valued at USD 9.94 billion in 2026 and is projected to surge around USD 19.00 billion by 2035 with a CAGR of 7.46%.
September 2026
The RNA interference drug delivery market was worth USD 139.58 billion in 2026, with key RNA interference drug delivery market players including Dicerna Pharmaceuticals (Acquired by Novo Nordisk), Silence Therapeutics, Ionis Pharmaceuticals.
September 2026
The last-mile delivery transportation market size is calculated at USD 203.36 billion in 2026 and is expected to hit around USD 487.20 billion by 2035, with a CAGR of 10.12%.
September 2026
The dental 3D printing devices market size is calculated at USD 15.36 billion in 2026 and is projected to hit around USD 72.27 billion by 2035, with a solid CAGR of 18.92%.
September 2026
The global pharmacy automation devices market size is projected to hit around USD 21.41 billion by 2035 from USD 9.16 billion in 2026, with a CAGR of 9.91%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com